These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37619856)

  • 1. Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies.
    Gao W; Gao S; Zhang Y; Wang M; Liu Y; Li T; Gao C; Zhou Y; Bian B; Wang H; Wei X; Sato T; Si N; Zhao W; Zhao H
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117073. PubMed ID: 37619856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the potential mechanism of Qingxin Lianzi Yin Decoction on renoprotection in db/db mice via network pharmacology and metabolomics.
    Gao WY; Tian MY; Li ML; Gao SR; Wei XL; Gao C; Zhou YY; Li T; Wang HJ; Bian BL; Si N; Zhao W; Zhao HY
    Phytomedicine; 2024 Apr; 126():155222. PubMed ID: 38382279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice.
    Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM
    Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology combined with metabolomics to study the mechanism of Shenyan Kangfu Tablets in the treatment of diabetic nephropathy.
    Wang X; He Q; Chen Q; Xue B; Wang J; Wang T; Liu H; Chen X
    J Ethnopharmacol; 2021 Apr; 270():113817. PubMed ID: 33444720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
    J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The integrated study on the chemical profiling and in vivo course to explore the bioactive constituents and potential targets of Chinese classical formula Qingxin Lianzi Yin Decoction by UHPLC-MS and network pharmacology approaches.
    Gao WY; Si N; Li ML; Gu XR; Zhang Y; Zhou YY; Wang HJ; Wei XL; Bian BL; Zhao HY
    J Ethnopharmacol; 2021 May; 272():113917. PubMed ID: 33609729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huperzine A targets Apolipoprotein E: A potential therapeutic drug for diabetic nephropathy based on omics analysis.
    Chen X; Zhang Y; Cao Z; Wang Y; Liao M; Guan Y; Zhu C; Wang W; Huang W; Li W; Xiao Y; Li Y; Yin J; Ding Y; Peng Q; Hu L
    Pharmacol Res; 2024 Oct; 208():107392. PubMed ID: 39233057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the metabolism and mechanism of acteoside in treating chronic glomerulonephritis.
    Gao W; Zhou Y; Li C; Liu T; Zhao H; Wang M; Wei X; Wang H; Yang J; Si N; Liang A; Bian B; Sato T
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115866. PubMed ID: 36332760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of mulberry leaf active components possessed synergetic effect on SD rats with diabetic nephropathy by mediating metabolism, Wnt/β-catenin and TGF-β/Smads signaling pathway.
    Ji T; Wang J; Xu Z; Cai HD; Su SL; Peng X; Ruan HS
    J Ethnopharmacol; 2022 Jun; 292():115026. PubMed ID: 35074452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics and molecular dynamics unveil the therapeutic potential of epalrestat in diabetic nephropathy.
    Song T; Wang R; Zhou X; Chen W; Chen Y; Liu Z; Men L
    Int Immunopharmacol; 2024 Oct; 140():112812. PubMed ID: 39094360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism.
    Guo X; Wu Y; Zhang C; Wu L; Qin L; Liu T
    Drug Des Devel Ther; 2021; 15():1577-1594. PubMed ID: 33883881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating metabolomics and network pharmacology to investigate Panax japonicus prevents kidney injury in HFD/STZ-induced diabetic mice.
    Wang T; Huang X; Zhai K; Yu J; Li J; Duan H; Liu J; Lu Z; Guo J; Li F
    J Ethnopharmacol; 2023 Mar; 303():115893. PubMed ID: 36368565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of metabolomics and network pharmacology for enhancing mechanism understanding and medication combination recommendation for diabetes mellitus and diabetic nephropathy.
    Xiao M; Liu W; Shi X; Wu J; Shen G; Feng J
    Anal Methods; 2023 Jul; 15(26):3173-3187. PubMed ID: 37338009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated lipidomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue Decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus.
    Sun L; Yang Z; Zhao W; Chen Q; Bai H; Wang S; Yang L; Bi C; Shi Y; Liu Y
    J Ethnopharmacol; 2022 Jan; 283():114699. PubMed ID: 34610419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on biomarkers of acteoside in treating puromycin aminonucleoside nephropathy in young rats based on non-targeted urine metabolomics technology].
    Wang MX; Luo KK; Gao WY; Tian MY; Zhao HY; Si N; Bian BL; Wei XL; Wang HJ; Zhou YY
    Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(21):5898-5907. PubMed ID: 38114186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic mechanism of PuRenDan for the treatment of diabetic nephropathy: Network pharmacology and experimental verification.
    Niu H; Fan L; Zhao L; Yao R; He X; Lu B; Pang Z
    J Ethnopharmacol; 2022 Jul; 293():115283. PubMed ID: 35427726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics study of cadmium-induced diabetic nephropathy and protective effect of caffeic acid phenethyl ester using UPLC-Q-TOF-MS combined with pattern recognition.
    Gong P; Chang X; Chen X; Bai X; Wen H; Pi S; Yang W; Wang L; Chen F
    Environ Toxicol Pharmacol; 2017 Sep; 54():80-92. PubMed ID: 28704754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway.
    Zhang Y; Yao H; Li C; Sun W; Chen X; Cao Y; Liu Y; Liu Y; Chen J; Qi J; Zhang Q; Zhang H; Xu A; Zhang J
    Oxid Med Cell Longev; 2022; 2022():6275505. PubMed ID: 35480869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy.
    Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J
    Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.